Enhanced antiscrapie effect using combination drug treatment.

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
• Protein-misfolding diseases share common pathogenic mechanisms.
• Effective treatments for TSEs are currently lacking.

Purpose of the Study:

• To evaluate the efficacy of a combination therapy for scrapie, a model TSE.
• To determine if pentosan polysulfate and Fe(III)meso-tetra(4-sulfonatophenyl)porphine act synergistically.

Main Methods:

• Mice were inoculated with scrapie.
• Combination treatment with pentosan polysulfate and Fe(III)meso-tetra(4-sulfonatophenyl)porphine was initiated at 14 or 28 days post-inoculation.
• Survival times were monitored.

Main Results:

• Combination therapy significantly increased survival times in scrapie-infected mice.
• The observed increase in survival suggests a synergistic effect between the two compounds.
• Treatment initiated later post-inoculation still demonstrated efficacy.

Conclusions:

• Combination therapy with pentosan polysulfate and Fe(III)meso-tetra(4-sulfonatophenyl)porphine is a promising therapeutic strategy for TSEs.
• The synergistic action of these compounds in vivo warrants further investigation.
• This approach may be applicable to other protein-misfolding diseases.